These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 11923060

  • 1. Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union.
    Schug BS, Brendel E, Wolf D, Wonnemann M, Wargenau M, Blume HH.
    Eur J Pharm Sci; 2002 Apr; 15(3):279-85. PubMed ID: 11923060
    [Abstract] [Full Text] [Related]

  • 2. Significant food interactions observed with a nifedipine modified-release formulation marketed in the European Union.
    Wonnemann M, Schug B, Schmücker K, Brendel E, van Zwieten PA, Blume H.
    Int J Clin Pharmacol Ther; 2006 Jan; 44(1):38-48. PubMed ID: 16425970
    [Abstract] [Full Text] [Related]

  • 3. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
    Schug BS, Brendel E, Chantraine E, Wolf D, Martin W, Schall R, Blume HH.
    Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration.
    Anschütz M, Wonnemann M, Schug B, Toal C, Donath F, Pontius A, Pauli K, Brendel E, Blume H.
    Int J Clin Pharmacol Ther; 2010 Feb; 48(2):158-70. PubMed ID: 20137768
    [Abstract] [Full Text] [Related]

  • 6. Comparison of two marketed nifedipine modified-release formulations: an exploratory clinical food interaction study.
    Wonnemann M, Schug B, Anschütz M, Brendel E, De Nucci G, Blume H.
    Clin Ther; 2008 Jan; 30(1):48-58. PubMed ID: 18343242
    [Abstract] [Full Text] [Related]

  • 7. SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration.
    Tulloch SJ, Zhang Y, McLean A, Wolf KN.
    Pharmacotherapy; 2002 Nov; 22(11):1405-15. PubMed ID: 12432966
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetic profile of a new controlled-release isosorbide-5-mononitrate 60 mg scored tablet (Monoket Multitab).
    Stockis A, De Bruyn S, Deroubaix X, Jeanbaptiste B, Lebacq E, Nollevaux F, Poli G, Acerbi D.
    Eur J Pharm Biopharm; 2002 Jan; 53(1):49-56. PubMed ID: 11777752
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized, phase I, 3-way crossover study to examine the effects of food on the pharmacokinetics of single doses of 400 mg posaconazole oral suspension in healthy male Taiwanese subjects.
    Lin TY, Yang MH, Chang FY.
    Ther Drug Monit; 2013 Apr; 35(2):223-7. PubMed ID: 23503449
    [Abstract] [Full Text] [Related]

  • 11. Relative bioavailability of four controlled-release nifedipine products.
    Schall R, Müller FO, Hundt HK, Duursema L, Groenewoud G, Van Dyk M, Van Schalkwyk AM.
    Biopharm Drug Dispos; 1994 Aug; 15(6):493-503. PubMed ID: 7993987
    [Abstract] [Full Text] [Related]

  • 12. Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.
    Alkhalidi BA, Tamimi JJ, Salem II, Ibrahim H, Sallam AA.
    Clin Ther; 2008 Oct; 30(10):1831-43. PubMed ID: 19014838
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bioavailability of modified-release methylphenidate: influence of high-fat breakfast when administered intact and when capsule content sprinkled on applesauce.
    Lee L, Kepple J, Wang Y, Freestone S, Bakhtiar R, Wang Y, Hossain M.
    Biopharm Drug Dispos; 2003 Sep; 24(6):233-43. PubMed ID: 12973820
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effects of food on the bioavailability of fenofibrate administered orally in healthy volunteers via sustained-release capsule.
    Yun HY, Joo Lee E, Youn Chung S, Choi SO, Kee Kim H, Kwon JT, Kang W, Kwon KI.
    Clin Pharmacokinet; 2006 Sep; 45(4):425-32. PubMed ID: 16584288
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetic interactions of nifedipine and quinidine.
    Hippius M, Henschel L, Sigusch H, Tepper J, Brendel E, Hoffmann A.
    Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
    [Abstract] [Full Text] [Related]

  • 20. Enhanced dissolution and oral bioavailability of nifedipine by spontaneous emulsifying powders: effect of solid carriers and dietary state.
    Weerapol Y, Limmatvapirat S, Jansakul C, Takeuchi H, Sriamornsak P.
    Eur J Pharm Biopharm; 2015 Apr; 91():25-34. PubMed ID: 25615879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.